SRPK2 and cancer: Increases in SRPK1 and SRPK2 were observed in a wide range of distinct cancers, including breast cancer, colorectal cancer, lung cancer, ovarian cancer, hepatocellular carcinoma, pancreatic cancer, leukemia, and gliomas [33,34,35,36].